- Intended Audience: Pharmacists interested in pharmacogenomics.
- Universal Activity Number: 0012-0000-20-036-H01-P
- Contact Hours: 25.0
- Program Fees: $699.00
- Dates Available: 08/10/2020 to 08/10/2023
- Activity Type: Practice/Certificate Program
This fully online, self-paced certificate program will equip the pharmacist with the knowledge necessary to implement pharmacogenomics into clinical practice. Leading experts in the field of pharmacogenomics will provide content focusing on the background of pharmacogenomics, pharmacogenomic testing, clinical implications of pharmacogenomics in cardiology, oncology, pain management, psychiatry, and ADRs. Experts will also discuss clinical implementation of pharmacogenomics in a variety of settings. Learners who earn the certificate will be able to use pharmacogenomics resources, apply pharmacogenomics to clinical care, and implement pharmacogenomics in diverse clinical settings.
Participants who successfully complete the program will also receive a certificate of completion.
Pre-Course Content: Principles of Genetic Medicine (optional)
This material is intended as pre-coursework and is not a required component of the certificate program or associated with continuing pharmacy education credit. This content will provide the foundational knowledge needed to guide the learner through the certificate.
Module 1: Science of Pharmacogenomics
This module will define pharmacogenetics and pharmacogenomics and outline the benefits of genomic medicine. Content will focus specifically on pharmacogenomics of drug metabolism and drug transporters.
Module 2: Fundamentals of Clinical Pharmacogenomics and Pharmacogenomic Testing
This module will define the CPIC guidelines and explain how they can be used by clinicians to make specific prescribing decisions for patient care when genetic information is available. It will also review available evidence sources for pharmacogenomic recommendations and explain strategies for using the Pharmacogenomics Knowledgebase (PharmGKB) to assess the usefulness and practical applications of pharmacogenomic information in the clinical setting. Content will also review clinical laboratory and direct-to-consumer pharmacogenomic testing.
Module 3: Clinical Pharmacogenomics: Cardiology and Oncology
This module will discuss clinical implications of genetic variability in oncology pharmacotherapy and patient-specific, genetic, and other factors that inform drug therapy changes in oncology. It will also summarize clinical implications of genetic variability on cardiovascular drug response and explain factors influencing the clinical implementation of genotyping to help guide cardiovascular drug therapy.
Module 4: Clinical Pharmacogenomics: Pain Management, Psychiatry, and ADRs
This module will identify medications affected by multiple genes and summarize the clinical implications of genetic variability in pain management and psychiatry. Content will specifically focus on pain management, adverse drug reactions/hypersensitivity, and psychiatry pharmacogenetics.
Module 5: Clinical Implementation of Pharmacogenomics
This module will summarize how to develop a clinical pharmacogenomic service, manage testing and reimbursement for pharmacogenetic results, and design electronic and written documentation. Content will focus on clinical decision support, patient and provider education, and challenges and solutions for implementing pharmacogenomics in diverse practice settings.
The following speakers, reviewers, and planning committee members have disclosed that he/she has no relevant financial disclosures. No one else in a position to control content has any financial relationships to disclose.
Amanda Elchynski, PharmD, BCPS
Caitrin W McDonough, Ph.D.
Emily J Cicali, Pharm.D.
Julio Duarte, Pharm.D., Ph.D.
Kelsey Cook, Pharm.D., BCPS
Kristin Wiisanen, Pharm.D., FAPhA, FCCP
Larisa H Cavallari, Pharm.D., BCPS, FCCP
Meghan J Arwood, Pharm.D., M.S., BCPS
Scott A. Mosley, PharmD
Schedule of Activities and Requirements for Successful Course Completion
To successfully pass this course the participant must complete the following:
- View all recorded lectures
- Complete all learning assessments
- Complete all case assignments
All program content must be submitted and the participant must achieve a passing score of 80% or more on all course assignments to receive continuing education credit and a certificate of completion.
The Office of Continuing Pharmacy Education can mail you a printed certificate of completion for an additional $25.00. Contact us for more information.
- The University of Florida College of Pharmacy will report CPE credit to CPE Monitor and CE Broker when applicable. If you would like a paper statement of credit, you may print it from your NABP e-profile.
- All pharmacists and pharmacy technicians maintain their own license and/or certification and it is their responsibility to follow up with the Office of Continuing Education at the University of Florida if any CE credit discrepancies are found.
- It is at the University’s discretion to award or deny credit to a late claiming participant (i.e. after 60 days of the participant engaging in a CPE activity) as it is the University’s CE activity and the provider needs to ensure the requirements necessary for credit are successfully completed.
- The University may request access to CPE Monitor® if the activity in question occurred within the previous 6 months and with an appropriate reason for access, i.e. power outage, etc.
Program Financial Support
This course received no financial program support.
Computer and Internet access are required to complete this course. Course content is provided via Canvas.
This course in its entirety is copyrighted by the University of Florida Continuing Pharmacy Education and may not be duplicated or reproduced for any other purpose without specific written permission.
The University of Florida College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.